Novartis Gene Therapies request
Novartis Gene Therapies wants to ensure that physicians, researchers, and other healthcare professionals have access to complete, up-to-date, and balanced scientific information regarding gene therapy treatment, research and investigational therapies.
Contact Novartis Gene Therapies
Please direct any of your medical inquiries to the Novartis Gene Therapies MedInfo team in the US, Europe, Middle East and Asia, Latin America & Canada, or Asia-Pacific.
Side effects of Novartis medicines can be reported online or to local Novartis Drug Safety Responsible at report.novartis.com.
Managed Access Program
The Novartis Gene Therapies "Managed Access Program" makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.